|
|
|
|
Summer Street Initiates Coverage of Salix Pharmaceuticals (SLXP) with a Buy
Summer Street initiates coverage of Salix Pharmaceuticals (NASDAQ: SLXP) with a Buy rating.Price target of $38. Soleil analyst says, "While shares have significantly appreciated in recent months, we see continued strength ahead. Xifaxan label...
|
|
|
Analyst expects FDA to approve Salix drug to treat neurological damage from liver failure
NEW YORK An Oppenheimer analyst said Tuesday that Salix Pharmaceuticals Ltd.will win new marketing approval for its drug Xifaxan, driving up sales and boosting the company's profit and sales for the year. John Newman said he thinks the Food and Drug...
|
|
|
Actionable Call Alert : Salix Pharmaceuticals (NASDAQ:SLXP): Top Pick For 2010 - Piper
Piper Jaffray is out with a major call on Salix Pharmaceuticals (NASDAQ:SLXP) this morning calling the stock their Top Small Cap Pick for 2010 and raising target to $58 (prev.$29). The firm believes that Street estimates (including their own) have been...
|
|
|
Piper Jaffray Names Salix Pharmaceuticals (SLXP) as Top Small Cap Pick for 2010
Piper Jaffray maintains an Overweight rating on Salix Pharmaceuticals (Nasdaq: SLXP), raises price target from $29 to $58.Piper analyst says, "We are highlighting Salix as our top small-cap specialty pharma pick in 2010. We believe that Street estimates ...
|
|
|
UPDATE 1-At least two brokerages up Salix Pharma price target
Jan 5 (Reuters) - Piper Jaffray and Roth Capital raised their price targets on Salix Pharmaceuticals Inc, citing higher price potential for the company's key drug Xifaxan.While Roth Capital raised its target to $30 from $27, Piper Jaffray doubled its...
|
|
|
Salix Pharmaceuticals up 6.5% on Piper Jaffray Share Pricing (SLX...
Company: Salix Pharmaceuticals, Ltd.(SLXP) 01/05/2010-Shares of Salix Pharmaceuticals (NASDAQ:SLXP) are trading up 6.7% to $27.74 in afternoon activity on Tuesday and earlier surged $28.36, the highest intraday price since November 2000. Piper Jaffray,...
|
|
|
STOCKS NEWS US-Salix Pharma gains after brokers up targets
Stocks on the move Real-time Equity news U.S.stock market report 1132 EST 5Jan2010-Salix Pharma gains after brokers up targets Shares of Salix Pharmaceuticals Inc rose on Tuesday after a pair of brokers raised their price targets on the stock, citing...
|
|
|
Salix Pharmaceuticals to Present at Piper Jaffray Conference
- Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that the Company will present at the Piper Jaffray 21st Annual Health Care Conference in New York, NY on Tuesday, December 1 at 10:00 a.m. Interested parties can access a live audio web cast of the...
|
|
|
Salix Pharmaceuticals to Present at Piper Jaffray Conference
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP - News) today announced that the Company will present at the Piper Jaffray 21st Annual Health Care Conference in New York, NY on Tuesday, December 1 at 10:00 a.m. Interested parties...
|
